GlassScriptPhysician profile
Roy W Ashton
NPI 1821147091
$706.50
in general payments reported to CMS, 2019-2025
12 companies · $45.39 in 2025
The $45.39 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $141 · 2021: $152 · 2023: $259 · 2025: $45.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $218 · Food and Beverage: $86.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $218.00 |
| Food and Beverage | $86.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $218.00 | 2023 | Dr Comfort |
| Rikco International, LLC | $93.00 | 2021 | |
| Sandoz INC. | $82.77 | 2019-2020 | |
| Ibsa Pharma INC. | $78.32 | 2021-2023 | Tirosint, Licart |
| Integra Lifesciences Corporation | $49.31 | 2019 | |
| Horizon Therapeutics Plc | $47.39 | 2020 | |
| Journey Medical Corporation | $45.28 | 2020-2023 | |
| Treace Medical Concepts, INC. | $24.21 | 2025 | |
| Pylant Medical | $21.18 | 2025 | |
| Zyla Life Sciences, INC. | $17.12 | 2020 | |
| Alfasigma USA, INC. | $15.37 | 2020 | |
| Sebela Pharmaceuticals INC. | $14.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Ashton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.